Active	Status	Sponsor type	Region	Phase	Filter
4 Active 8 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Boulware, David R
EnACT3, NCT05541107: Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3	Not yet recruiting	3	270	NA	MAT2203, cAMB, Amphotericin B	Matinas BioPharma Nanotechnologies, Inc., University of Minnesota	Cryptococcal Meningitis	10/24	01/25
PLATFORM-CM, NCT06666322: Platform Trial For Cryptococcal Meningitis	Not yet recruiting	2/3	2000	NA	Standard of care, Oteseconazole - antifungal therapy 1, Sfu-AM2-19 Injection - antifungal therapy 2, Antifungal therapy 3, Antifungal therapy 4	University of Minnesota	Hiv, Cryptococcal Meningitis	02/32	02/32
NCT06414512: Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal Meningitis	Completed	2	47	RoW	AMBITION trial control, Flucytosine	University of Minnesota	Cryptococcal Meningitis	10/24	10/24
NCT04604561: Evaluation of EnVisio SmartClip for Intraoperative Localization of Breast Masses	Completed	N/A	50	US	EnVisio SmartClip, EnVisio™ Navigation System	H. Lee Moffitt Cancer Center and Research Institute, Elucent Medical	Breast Cancer	07/23	07/23